RUA Life Sciences (RUA) Competitors GBX 14.75 0.00 (0.00%) (As of 10/11/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors RUA vs. BELL, POLX, IHC, AVO, MHC, SUN, DEMG, SN, MXCT, and NIOXShould you be buying RUA Life Sciences stock or one of its competitors? The main competitors of RUA Life Sciences include Belluscura (BELL), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Deltex Medical Group (DEMG), Smith & Nephew (SN), MaxCyte (MXCT), and NIOX Group (NIOX). These companies are all part of the "medical devices" industry. RUA Life Sciences vs. Belluscura Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy MyHealthChecked Surgical Innovations Group Deltex Medical Group Smith & Nephew MaxCyte NIOX Group RUA Life Sciences (LON:RUA) and Belluscura (LON:BELL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation, media sentiment, profitability and risk. Does the media prefer RUA or BELL? In the previous week, RUA Life Sciences' average media sentiment score of 0.00 equaled Belluscura'saverage media sentiment score. Company Overall Sentiment RUA Life Sciences Neutral Belluscura Neutral Which has more risk and volatility, RUA or BELL? RUA Life Sciences has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Comparatively, Belluscura has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Which has stronger valuation and earnings, RUA or BELL? RUA Life Sciences has higher revenue and earnings than Belluscura. RUA Life Sciences is trading at a lower price-to-earnings ratio than Belluscura, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRUA Life Sciences£2.19M4.18-£1.44M-£0.04-368.75Belluscura£1.80M11.23-£18.60M-£0.10-120.00 Do insiders & institutionals believe in RUA or BELL? 26.0% of RUA Life Sciences shares are held by institutional investors. Comparatively, 6.3% of Belluscura shares are held by institutional investors. 51.3% of RUA Life Sciences shares are held by insiders. Comparatively, 56.3% of Belluscura shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in RUA or BELL? RUA Life Sciences and Belluscura both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRUA Life SciencesOutperform VotesNo VotesUnderperform Votes6100.00% BelluscuraN/AN/A Do analysts recommend RUA or BELL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RUA Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABelluscura 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Is RUA or BELL more profitable? Belluscura has a net margin of 0.00% compared to RUA Life Sciences' net margin of -65.72%. RUA Life Sciences' return on equity of -24.27% beat Belluscura's return on equity.Company Net Margins Return on Equity Return on Assets RUA Life Sciences-65.72% -24.27% -17.50% Belluscura N/A -85.01%-43.53% SummaryRUA Life Sciences beats Belluscura on 7 of the 11 factors compared between the two stocks. Ad Porter & CompanyElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Get RUA Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RUA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RUA vs. The Competition Export to ExcelMetricRUA Life SciencesMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£9.15M£2.15B£5.42B£1.54BDividend Yield1.44%2.26%4.48%11.69%P/E Ratio-368.75235.73127.781,606.44Price / Sales4.18169.171,254.82200,995.28Price / Cash2.4015.5839.2825.27Price / Book1.233.284.692.83Net Income-£1.44M£41.32M£115.85M£139.44M7 Day Performance4.74%-1.66%0.56%-0.18%1 Month Performance37.86%-0.30%17.04%-0.42%1 Year Performance1.72%24.30%29.21%26.06% RUA Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RUARUA Life SciencesN/AGBX 14.75flatN/A-3.5%£9.15M£2.19M-368.7548BELLBelluscuraN/AGBX 12-2.0%N/A-61.2%£20.21M£1.20M-109.0924Gap DownPOLXPolarean ImagingN/AGBX 1.40flatN/A-83.8%£16.94M£1.87M-70.0028Gap DownIHCInspiration Healthcare GroupN/AGBX 17.75-4.1%N/A-40.5%£15.92M£34.30M-126.79210News CoverageAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900News CoverageGap DownMHCMyHealthCheckedN/AGBX 13-1.9%N/A+14.8%£6.76M£10.98M-650.0021SUNSurgical Innovations GroupN/AGBX 0.50-9.1%N/A-44.8%£4.66M£12.54M-21.112,300News CoverageDEMGDeltex Medical GroupN/AGBX 0.11flatN/A-37.3%£2.00M£1.78M-5.7537SNSmith & Nephew3.1762 of 5 starsGBX 1,101-3.2%GBX 3,956.20+259.3%+11.4%£9.60B£5.64B4,077.7818,452High Trading VolumeMXCTMaxCyteN/AGBX 287+1.1%N/A+16.7%£301.61M£45.44M-1,148.0080Gap DownNIOXNIOX GroupN/AGBX 67.80+2.1%N/A+8.4%£287.50M£39M3,390.0092News CoverageGap Up Related Companies and Tools Related Companies: BELL Competitors POLX Competitors IHC Competitors AVO Competitors MHC Competitors SUN Competitors DEMG Competitors SN Competitors MXCT Competitors NIOX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:RUA) was last updated on 10/12/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredThe Crypto Whisperer Just Sounded the AlarmThe 2024 Altcoin Eruption is Almost Here (Get in by Nov. 4) In late 2020, Ian King urged his readers to tak...Banyan Hill Publishing | SponsoredDon’t Miss Out: Elon’s Game-Changing InventionWhen you click here you'll discover what Elon Musk's newest invention can do… And how it works… You migh...InvestorPlace | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RUA Life Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share RUA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
